Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone

被引:10
作者
Johansson, H. R. [2 ]
Skripitz, R. [1 ]
Aspenberg, P. [3 ]
机构
[1] Univ Hosp Rostock, Dept Orthopaed, D-18055 Rostock, Germany
[2] Univ Hamburg, Hosp Eppendorf, Dept Trauma Hand & Reconstruct Surgery, D-20246 Hamburg, Germany
[3] Linkoping Univ, Fac Hlth Sci, Dept Neurosci & Locomot, Sect Orthopaed & Sports Med, S-58183 Linkoping, Sweden
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 2008年 / 90B卷 / 03期
关键词
D O I
10.1302/0301-620X.90B3
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
We have examined the deterioration of implant fixation after withdrawal of parathyroid hormone (PTH) in rats. First, the pull-out force for stainless-steel screws in the proximal tibia was measured at different times after withdrawal. The stimulatory effect of PTH on fixation was lost after 16 days. We then studied whether bisphosphonates could block this withdrawal effect. Mechanical and histomorphometric measurements were conducted for five weeks after implantation. Subcutaneous injections were given daily. Specimens treated with either PTH or saline during the first two weeks showed no difference in the mechanical or histological results (pull-out force 76 N vs 81 N; bone volume density 19% vs 20%). Treatment with PTH for two weeks followed by pamidronate almost doubled the pull-out force (152 N; p < 0.001) and the bone volume density (37%; ANOVA, p < 0.001). Pamidronate alone did not have this effect (89 N and 25%, respectively). Thus, the deterioration can be blocked by bisphosphonates. The clinical implications are discussed.
引用
收藏
页码:400 / 404
页数:5
相关论文
共 27 条
[1]   Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures [J].
Andreassen, TT ;
Ejersted, C ;
Oxlund, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) :960-968
[2]  
ASPENBERG P, 1998, CLIN ORTHOP RELAT R, V352, P75
[3]   Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism [J].
Bellido, T ;
Ali, AA ;
Plotkin, LI ;
Fu, Q ;
Gubrij, I ;
Roberson, PK ;
Weinstein, RS ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50259-50272
[4]   Changes in serum receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34) [J].
Buxton, EC ;
Yao, W ;
Lane, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3332-3336
[5]   EVIDENCE THAT INTERMITTENT TREATMENT WITH PARATHYROID-HORMONE INCREASES BONE-FORMATION IN ADULT-RATS BY ACTIVATION OF BONE LINING CELLS [J].
DOBNIG, H ;
TURNER, RT .
ENDOCRINOLOGY, 1995, 136 (08) :3632-3638
[6]   Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats [J].
Ejersted, C ;
Andreassen, TT ;
Hauge, EM ;
Melsen, F ;
Oxlund, H .
BONE, 1995, 17 (06) :507-511
[7]   Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism [J].
Friedl, Gerald ;
Turner, Russell T. ;
Evans, Glenda L. ;
Dobnig, Harald .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2007, 25 (11) :1454-1464
[8]   LOSS OF THE ANABOLIC EFFECT OF PARATHYROID-HORMONE ON BONE AFTER DISCONTINUATION OF HORMONE IN RATS [J].
GUNNESSHEY, M ;
HOCK, JM .
BONE, 1989, 10 (06) :447-452
[9]   A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis [J].
Hodsman, AB ;
Fraher, LJ ;
Watson, PH ;
Ostbye, T ;
Stitt, LW ;
Adachi, JD ;
Taves, DH ;
Drost, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :620-628
[10]   AN EVALUATION OF SEVERAL BIOCHEMICAL MARKERS FOR BONE-FORMATION AND RESORPTION IN A PROTOCOL UTILIZING CYCLICAL PARATHYROID-HORMONE AND CALCITONIN THERAPY FOR OSTEOPOROSIS [J].
HODSMAN, AB ;
FRAHER, LJ ;
OSTBYE, T ;
ADACHI, JD ;
STEER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1138-1148